BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,523,902 | -22.9% | 468,417 | -2.9% | 0.01% | -22.2% |
| Q2 2023 | $30,492,926 | +43.3% | 482,483 | +2.0% | 0.01% | +50.0% |
| Q1 2023 | $21,275,321 | +3.7% | 472,890 | +0.9% | 0.01% | -14.3% |
| Q4 2022 | $20,523,189 | -32.0% | 468,459 | +2.3% | 0.01% | -36.4% |
| Q3 2022 | $30,159,000 | +34.1% | 457,709 | +2.8% | 0.01% | +37.5% |
| Q2 2022 | $22,488,000 | -21.4% | 445,218 | -0.6% | 0.01% | -11.1% |
| Q1 2022 | $28,609,000 | -39.0% | 447,849 | +2.2% | 0.01% | -35.7% |
| Q4 2021 | $46,914,000 | -2.0% | 437,995 | -5.9% | 0.01% | -12.5% |
| Q3 2021 | $47,870,000 | +17.8% | 465,609 | +0.8% | 0.02% | +14.3% |
| Q2 2021 | $40,637,000 | -6.7% | 461,993 | +3.2% | 0.01% | -12.5% |
| Q1 2021 | $43,536,000 | -5.9% | 447,755 | +8.6% | 0.02% | -11.1% |
| Q4 2020 | $46,248,000 | +26.8% | 412,374 | +4.8% | 0.02% | +5.9% |
| Q3 2020 | $36,486,000 | +19.0% | 393,592 | +0.2% | 0.02% | +13.3% |
| Q2 2020 | $30,655,000 | +43.5% | 393,002 | +7.6% | 0.02% | +15.4% |
| Q1 2020 | $21,366,000 | -13.8% | 365,355 | +18.1% | 0.01% | 0.0% |
| Q4 2019 | $24,792,000 | +11.0% | 309,471 | +1.8% | 0.01% | 0.0% |
| Q3 2019 | $22,340,000 | -17.2% | 304,059 | +6.4% | 0.01% | -18.8% |
| Q2 2019 | $26,967,000 | +37.1% | 285,873 | +16.4% | 0.02% | +23.1% |
| Q1 2019 | $19,665,000 | +53.9% | 245,648 | +3.7% | 0.01% | +30.0% |
| Q4 2018 | $12,776,000 | -30.6% | 236,975 | +0.5% | 0.01% | -16.7% |
| Q3 2018 | $18,407,000 | +39.2% | 235,803 | +13.2% | 0.01% | +20.0% |
| Q2 2018 | $13,223,000 | -27.3% | 208,295 | +5.1% | 0.01% | -28.6% |
| Q1 2018 | $18,180,000 | +28.0% | 198,253 | +5.3% | 0.01% | +27.3% |
| Q4 2017 | $14,202,000 | +20.7% | 188,320 | +11.5% | 0.01% | +10.0% |
| Q3 2017 | $11,763,000 | +49.5% | 168,835 | +8.7% | 0.01% | +42.9% |
| Q2 2017 | $7,870,000 | +75.0% | 155,306 | +38.1% | 0.01% | +40.0% |
| Q1 2017 | $4,498,000 | +90.5% | 112,458 | +33.6% | 0.01% | +66.7% |
| Q4 2016 | $2,361,000 | +0.1% | 84,152 | +6.0% | 0.00% | 0.0% |
| Q3 2016 | $2,359,000 | +165.7% | 79,416 | +81.2% | 0.00% | +200.0% |
| Q2 2016 | $888,000 | +92.6% | 43,823 | +71.8% | 0.00% | 0.0% |
| Q1 2016 | $461,000 | -30.0% | 25,503 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $659,000 | +26.7% | 24,993 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $520,000 | -13.3% | 24,343 | +7.6% | 0.00% | 0.0% |
| Q2 2015 | $600,000 | – | 22,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |